Russian Federation
Russian Federation
Russian Federation
Russian Federation
Irkutsk Scientific Center SB RAS (otdel mediko-biologicheskih issledovaniy i tehnologiy, zaveduyuschiy)
Irkutsk, Irkutsk region, Russian Federation
Purpose of the study. To rate prognostic properties of changes in mitochondrial DNA concentration in the blood plasma of patients with chronic cerebral ischemia and ischemic heart disease in relation to the disease and the effectiveness of the therapy. Materials and methods. The study involved patients suffering from coronary heart disease (CHD) and chronic cerebral ischemia (CCI) with stable and unstable atherosclerotic plaques, who have signed informed consent to the data processing within the framework of scientific research. The patients were admitted to the hospital for examination and treatment of CHD and CCI in Cardiology and Neurology Unit of the Hospital of ISC SB RAS. The subjects underwent laboratory and instrumental examination and analysis of the level of free circulating serum mitochondrial DNA by real-time PCR (copies/ml). The examination results considered as satisfactory were compared with the mtDNA levels before and after the treatment. Results. The average value of the mtDNA levels before and after the treatment in patients of neurological and cardiological profile were significantly different: 1 093 686 copies/ml vs 418 046 copies/ml, respectively (p = 0.02). Unlike women, men mtDNA levels statistically significantly (p = 0.03) decreased after the treatment. We revealed statistically significant differences in mtDNA level indicators before and after the treatment, depending on the definition of the series (p = 0.0010) for rank test Kruskal – Wallis test. The results of the proposed research will help to identify prognostic factors of destabilization of cell damage and plaques in endothelial dysfunction, atherosclerosis and its complications, to conduct clinical test of the method for predicting and diagnostics of cellular damage in chronic ischemia on a background of atherosclerosis.
clinical research, atherosclerosis, freely circulating mitochondrial DNA, coronary heart disease, c hronic c erebral isc hemia
В настоящее время наблюдается значительный прогресс в изучении и понимании сердечно-сосудистой патологии, тем не менее, остаётся ряд нерешённых вопросов в диагностике и прогнозе течения патологических процессов, что важно при выборе тактики лечения и реабилитации пациентов. Очевидно, что необходима разработка новых подходов к диагностике и выявлению факторов риска для данной категории больных. Разработка новых способов диагностики и прогнозирования органных и клеточных повреждений, выявление ключевых факторов рисков нестабильности течения эндотелиальной дисфункции и атеросклероза направлены на решение важнейшей проблемы современной медицины – профилактику, сохранение и укрепление здоровья населения.
1. Aparcin K.A., Grigor'ev E.G. Perspektivy translyacionnyh issledovaniy v Irkutskom nauchnom centre // XIX mezhdunar. Kongress hirurgov-gepatologov stran SNG «Aktual'nye problemy hirurgicheskoy gepatologii» (Irkutsk, 19–21 sent. 2012 g.): Sb. mater. –– Irkutsk, 2012. – S. 250.
2. Vybivanceva A.V., Aparcin K.A. Translyacionnye issledovaniya effektivnosti antikoagulyantnoy terapii // Fundamental'naya nauka i tehnologii – perspektivnye razrabotki: Mater. mezhdunar. nauch.-prakt. konf. (Moskva, 22–23 maya 2013 g.). – M., 2013. – S. 38–41.
3. Kireeva V.V., Aparcin K.A. Farmakogeneticheskoe testirovanie kak metod issledovaniya translyacionnoy mediciny // Nauka v sovremennom informacionnom obschestve: Mater. mezhdunar. nauch.-prakt. konf. (Moskva, 3–4 aprelya 2013 g.). – M., 2013. – T. 2. – S. 80–82.
4. Kireeva V.V., Lifshic G.I., Aparcin K.A. Translyacionnye issledovaniya faktorov tolerantnosti k povrezhdeniyu sosudistoy stenki i ee regeneratornogo potenciala // Nauka v sovremennom informacionnom obschestve: Mater. mezhdunar. nauch.-prakt. konf. (North Charleston, USA, 28–29 avgusta 2014 g.). – S. 42–44.
5. Kireeva V.V., Koh N.V., Lifshic G.I., Aparcin K.A. Disfunkciya endoteliya kak kraeugol'nyy kamen' serdechno-sosudistyh sobytiy: molekulyarno- i farmakogeneticheskie aspekty // Rossiyskiy kardiologicheskiy zhurnal. – 2014. – № 10 (114). – S. 64–68.
6. Sudakov N.P., Nikiforov S.B., Konstantinov Yu.M., Klimenkov I.V. i dr. Rol' perekisno-modificirovannyh lipoproteidov v mehanizmah razvitiya mitohondrial'noy disfunkcii sosudov pri aterogeneze // Byulleten' VSNC SO RAMN. – 2008. – № 4. – S. 85–89.
7. Sudakov N.P., Popkova T.P., Katyshev A.I., Gol'dberg O.A. i dr. Uroven' svobodno cirkuliruyuschey mitohondrial'noy DNK krovi pri dislipoproteidemii i adrenalinovom miokardite (eksperimental'noe issledovanie) // Izvestiya IGU. Seriya «Biologiya. Ekologiya». – 2011. – T. 4, № 4. – S. 136–142.
8. Sudakov N.P., Popkova T.P., Novikova M.A., Katyshev A.I. i dr. Vzaimosvyaz' urovnya svobodno cirkuliruyuschey mitohondrial'noy DNK krovi s aktivnost'yu markerov citoliza pri eksperimental'noy ostroy melkoochagovoy ishemii miokarda // Sibirskiy medicinskiy zhurnal. – 2013. – № 5. – S. 83–86.
9. Kireeva V.V., Lepehova S.A., Usol'cev Yu.K., Aparcin K.A. Translyacionnye metody diagnostiki mitohondrial'noy disfunkcii u pacientov s hronicheskoy ishemiey miokarda i/ili golovnogo mozga // Fundamental'naya nauka i tehnologii – perspektivnye razrabotki: Mater. IV mezhdunar. nauch.-prakt. konf. n.-i. c. «Akademicheskiy». – 2016. – S. 14–18.
10. Usol'cev Yu.K., Kireeva V.V., Aparcin K.A., Lifshic G.I. Issledovanie mitohondrial'noy disfunkcii u pacientov s hronicheskoy ishemiey miokarda i/ili golovnogo mozga: dizayn i procedury issledovaniya // Translyacionnaya medicina. – 2016. – № 3 (4). – S. 55–62.
11. Ricci F., De Caterina R. Isolatedcreatine kinase-MB rise with normal cardiac troponins: a strange occurrence with difficult interpretation // J. Cardiovasc. Med. – 2011. – Vol. 12. – P. 736–740.
12. Ellinger J., Müller S.C., Wernert N. et al. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of bio-chemical recurrence after prostatectomy // BJU Int. – 2008. – Vol. 102. – P. 628–632.
13. Madamanchi N.R., Runge M.S. Mitochondrial dysfunction in atherosclerosis // Circ. Res. – 2007. – Vol. 100. – P. 460–473.
14. Nakahira K., Kyung S.Y., Rogers A.J. et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation // PLoS Med. – 2013. – Vol. 10. –e1001577. doi: 10.1371/journal.pmed.1001577.
15. Zhang Q., Raoof M., Chen Y. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury // Nature. – 2010. – Vol. 464. – P. 104–107.
